Treatment of methicillin-resistant Staphylococcus aureus in Latin America

Treatment of methicillin-resistant Staphylococcus aureus in Latin America

The global spread of methicillin-resistant Staphylococcus aureus (MRSA) means it is now a pathogen of worldwide public health concern. Within Latin America, MRSA is highly prevalent, with the proportion of S. aureus isolates that are methicillin-resistant on the rise, yet resources for managing the infection are limited. While several guidelines exist for the treatment of MRSA infections, many are written for the North American or European setting and need adaptation for use in Latin America. In this article, we aim to emphasize the importance of appropriate treatment of MRSA in the healthcare and community settings of Latin America. We present a summary of the available guidelines and antibiotics, and discuss particular considerations for clinicians treating MRSA in Latin America

Saved in:
Bibliographic Details
Main Authors: Luna,Carlos M, Rodríguez-Noriega,Eduardo, Bavestrello,Luis, Gotuzzo,Eduardo
Format: Digital revista
Language:English
Published: Brazilian Society of Infectious Diseases 2010
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000800007
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1413-86702010000800007
record_format ojs
spelling oai:scielo:S1413-867020100008000072011-01-05Treatment of methicillin-resistant Staphylococcus aureus in Latin AmericaLuna,Carlos MRodríguez-Noriega,EduardoBavestrello,LuisGotuzzo,Eduardo MRSA treatment antibiotic therapy Latin America The global spread of methicillin-resistant Staphylococcus aureus (MRSA) means it is now a pathogen of worldwide public health concern. Within Latin America, MRSA is highly prevalent, with the proportion of S. aureus isolates that are methicillin-resistant on the rise, yet resources for managing the infection are limited. While several guidelines exist for the treatment of MRSA infections, many are written for the North American or European setting and need adaptation for use in Latin America. In this article, we aim to emphasize the importance of appropriate treatment of MRSA in the healthcare and community settings of Latin America. We present a summary of the available guidelines and antibiotics, and discuss particular considerations for clinicians treating MRSA in Latin Americainfo:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.14 suppl.2 20102010-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000800007en10.1590/S1413-86702010000800007
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Luna,Carlos M
Rodríguez-Noriega,Eduardo
Bavestrello,Luis
Gotuzzo,Eduardo
spellingShingle Luna,Carlos M
Rodríguez-Noriega,Eduardo
Bavestrello,Luis
Gotuzzo,Eduardo
Treatment of methicillin-resistant Staphylococcus aureus in Latin America
author_facet Luna,Carlos M
Rodríguez-Noriega,Eduardo
Bavestrello,Luis
Gotuzzo,Eduardo
author_sort Luna,Carlos M
title Treatment of methicillin-resistant Staphylococcus aureus in Latin America
title_short Treatment of methicillin-resistant Staphylococcus aureus in Latin America
title_full Treatment of methicillin-resistant Staphylococcus aureus in Latin America
title_fullStr Treatment of methicillin-resistant Staphylococcus aureus in Latin America
title_full_unstemmed Treatment of methicillin-resistant Staphylococcus aureus in Latin America
title_sort treatment of methicillin-resistant staphylococcus aureus in latin america
description The global spread of methicillin-resistant Staphylococcus aureus (MRSA) means it is now a pathogen of worldwide public health concern. Within Latin America, MRSA is highly prevalent, with the proportion of S. aureus isolates that are methicillin-resistant on the rise, yet resources for managing the infection are limited. While several guidelines exist for the treatment of MRSA infections, many are written for the North American or European setting and need adaptation for use in Latin America. In this article, we aim to emphasize the importance of appropriate treatment of MRSA in the healthcare and community settings of Latin America. We present a summary of the available guidelines and antibiotics, and discuss particular considerations for clinicians treating MRSA in Latin America
publisher Brazilian Society of Infectious Diseases
publishDate 2010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000800007
work_keys_str_mv AT lunacarlosm treatmentofmethicillinresistantstaphylococcusaureusinlatinamerica
AT rodrigueznoriegaeduardo treatmentofmethicillinresistantstaphylococcusaureusinlatinamerica
AT bavestrelloluis treatmentofmethicillinresistantstaphylococcusaureusinlatinamerica
AT gotuzzoeduardo treatmentofmethicillinresistantstaphylococcusaureusinlatinamerica
_version_ 1756416420468490240

Similar Items